• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

New and Upcoming Therapies in Atopic Dermatitis

Author(s):

James Song, MD, FAAD

James Song, MD, FAAD, discusses how recent advancements in atopic dermatitis treatment include targeted biologics and Janus kinase inhibitors that offer promising alternatives to traditional therapies for patients with moderate-to-severe disease.

Current Time 0:00
Duration 8:18
Loaded: 0%
Stream Type LIVE
Remaining Time 8:18
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Newsletter

    Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

    Subscribe Now!
    Related Videos
    LEVEL UP Trial Sets New Benchmark for Atopic Dermatitis Treatment
    LEVEL UP Trial Sets New Benchmark for Atopic Dermatitis Treatment
    How OX40-Targeted Therapies Might Reshape Biologic Strategy in AD
    How OX40-Targeted Therapies Might Reshape Biologic Strategy in AD
    Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
    Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
    Understanding the Role of OX40 in Next-Generation Eczema Therapies
    Understanding the Role of OX40 in Next-Generation Eczema Therapies
    Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
    Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
    The Vicious Cycle of Itch, Stress, and Sleep Loss
    The Vicious Cycle of Itch, Stress, and Sleep Loss
    Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
    Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
    1 expert in this video
    Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management
    1 expert in this video
    Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice
    1 expert in this video
    Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments
    Related Content
    Prolonged Use of Oral Corticosteroids in Atopic Dermatitis Linked to Increased Cardiovascular Risks
    May 14th 2025

    Prolonged Use of Oral Corticosteroids in Atopic Dermatitis Linked to Increased Cardiovascular Risks

    Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
    March 31st 2025

    Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine

    What to Know When Targeting IL-13 vs IL-31 in Atopic Dermatitis
    May 13th 2025

    What to Know When Targeting IL-13 vs IL-31 in Atopic Dermatitis

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
    August 2nd 2024

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

    Closing the Gap in Pediatric Atopic Dermatitis: Experts Push for Steroid-Free Advancements
    May 12th 2025

    Closing the Gap in Pediatric Atopic Dermatitis: Experts Push for Steroid-Free Advancements

    Advancing Atopic Dermatitis Treatment by Understanding the Role of Multitargeted Therapies
    May 12th 2025

    Advancing Atopic Dermatitis Treatment by Understanding the Role of Multitargeted Therapies

    © 2025 MJH Life Sciences

    All rights reserved.